FDA approves gene therapy for inherited forms of vision loss
December 21, 2017
» Continue to this story on UPI
CWN Editor's Note: In its 2008 instruction Dignitas Personae, the Congregation for the Doctrine of the Faith discussed gene therapy (nos. 25-27). Procedures “used on somatic cells for strictly therapeutic purposes are in principle morally licit,” while germ line cell therapy, which seeks to influence potential offspring, is morally illicit “in its current state ... in all its forms.” This particular procedure, as described here, is an example of somatic cell gene therapy.
The above note supplements, highlights, or corrects details in the original source (link above). About CWN news coverage.
For all current news, visit our News home page.
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
